A phase I clinical trial of flavone-8-acetic acid in combination with interleukin 2

Jon T. Holmlund, William C. Kopp, Robert H. Wiltrout, Dan L. Longo, Walter J. Urba, John Edward Janik, Mario Sznol, Kevin C. Conlon, Robert G. Fenton, Ronald Hornung, Karen Madara, Mary Ann Shields, John W. Smith, William Sharfman, Ronald G. Steis, Cynthia Ewel, Louis Malspeis, Stephen P. Creekmore

Research output: Contribution to journalComment/debate

7 Scopus citations
Original languageEnglish (US)
Pages (from-to)134-136
Number of pages3
JournalJournal of the National Cancer Institute
Volume87
Issue number2
DOIs
StatePublished - Jan 18 1995

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Holmlund, J. T., Kopp, W. C., Wiltrout, R. H., Longo, D. L., Urba, W. J., Janik, J. E., Sznol, M., Conlon, K. C., Fenton, R. G., Hornung, R., Madara, K., Shields, M. A., Smith, J. W., Sharfman, W., Steis, R. G., Ewel, C., Malspeis, L., & Creekmore, S. P. (1995). A phase I clinical trial of flavone-8-acetic acid in combination with interleukin 2. Journal of the National Cancer Institute, 87(2), 134-136. https://doi.org/10.1093/jnci/87.2.134